Differential Diagnosis of Unipolar Versus Bipolar Depression by GSK3 Levels in Peripheral Blood: a Pilot Experimental Study

Overview

Journal Int J Bipolar Disord

Date 2023 Oct 8

PMID 37807001

Authors

Gianluca Rosso

Giuseppe Maina

Elena Teobaldi

Ilaria Balbo

Gabriele Di Salvo

Francesca Montarolo

Nicola Rizzo Pesci

Filippo Tempia

Eriola Hoxha

Affiliations

Soon will be listed here.

Abstract

Background: The differential diagnosis of patients presenting for the first time with a depressive episode into unipolar disorder versus bipolar disorder is crucial to establish the correct pharmacological therapy (antidepressants vs mood stabilizers), but no biological markers are currently available. Several lines of evidence indicate an involvement of Glycogen Synthase Kinase-3 (GSK3) in the pathophysiology of depression. However, previous reports about GSK3 in peripheral blood were incomplete or inconsistent, so a specific marker is not yet available. The aim was to search for consistent differences in GSK3α and GSK3β or of their phosphorylated forms in samples of peripheral blood from patients with unipolar and bipolar depression.

Methods: Mononucleate peripheral blood cells (PBMCs) of samples from patients presenting with a depressive episode were analyzed with the western blot technique.

Results: The total amount of GSK3β in PBMCs was significantly lower in patients with bipolar disorder than in patients with unipolar depression. The sensitivity based on GSK3β was 85%. GSK3α was not significantly different but allowed a correct detection of 57% of BD patients. The combination in series of GSK3β and GSK3α yields a sensitivity of about 100%, but with 26.7% false negatives.

Conclusions: Our results suggest that PBMC GSK3β could be a candidate biomarker for the differential diagnosis of bipolar disorder versus unipolar depression. This finding may help in implementing the still limited panel of peripheral biomarkers for differential diagnosis between unipolar and bipolar disorder in patients presenting with a depressive episode.

Citing Articles

Comparison of clinical features and inflammatory factors between patients with bipolar depression and unipolar depression.

Zhang T, Ji C, Zhu J, Wang X, Shen C, Liang F BMC Psychiatry. 2025; 25(1):108.

PMID: 39930379 PMC: 11812187. DOI: 10.1186/s12888-025-06516-w.

A review of diffusion MRI in mood disorders: mechanisms and predictors of treatment response.

Al-Sharif N, Zavaliangos-Petropulu A, Narr K Neuropsychopharmacology. 2024; 50(1):211-229.

PMID: 38902355 PMC: 11525636. DOI: 10.1038/s41386-024-01894-3.

References

Beurel E, Grieco S, Jope R . Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther. 2014; 148:114-31. PMC: 4340754. DOI: 10.1016/j.pharmthera.2014.11.016. View

Carvalho A, Dimellis D, Gonda X, Vieta E, Mclntyre R, Fountoulakis K . Rapid cycling in bipolar disorder: a systematic review. J Clin Psychiatry. 2014; 75(6):e578-86. DOI: 10.4088/JCP.13r08905. View

Sousa R, Zanetti M, Talib L, Serpa M, Chaim T, Carvalho A . Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes. J Psychiatr Res. 2015; 62:78-83. DOI: 10.1016/j.jpsychires.2015.01.016. View

Diniz B, Talib L, Joaquim H, de Paula V, Gattaz W, Forlenza O . Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?. World J Biol Psychiatry. 2011; 12(3):216-22. DOI: 10.3109/15622975.2010.551408. View

Duda P, Hajka D, Wojcicka O, Rakus D, Gizak A . GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness. Cells. 2020; 9(3). PMC: 7140610. DOI: 10.3390/cells9030727. View

Embi N, Rylatt D, Cohen P . Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem. 1980; 107(2):519-27. View

Fornaro M, Anastasia A, Novello S, Fusco A, Solmi M, Monaco F . Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis. Bipolar Disord. 2018; 20(3):195-227. DOI: 10.1111/bdi.12612. View

Frame S, Cohen P . GSK3 takes centre stage more than 20 years after its discovery. Biochem J. 2001; 359(Pt 1):1-16. PMC: 1222116. DOI: 10.1042/0264-6021:3590001. View

Grimes C, Jope R . The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001; 65(4):391-426. DOI: 10.1016/s0301-0082(01)00011-9. View

10.

Hamilton M . The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32(1):50-5. DOI: 10.1111/j.2044-8341.1959.tb00467.x. View

11.

Hamilton M . Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6(4):278-96. DOI: 10.1111/j.2044-8260.1967.tb00530.x. View

12.

Hur E, Zhou F . GSK3 signalling in neural development. Nat Rev Neurosci. 2010; 11(8):539-51. PMC: 3533361. DOI: 10.1038/nrn2870. View

13.

Jacoby A, Munkholm K, Vinberg M, Joaquim H, Talib L, Gattaz W . Glycogen synthase kinase-3β in patients with bipolar I disorder: results from a prospective study. Bipolar Disord. 2016; 18(4):334-41. DOI: 10.1111/bdi.12400. View

14.

Karege F, Perroud N, Burkhardt S, Schwald M, Ballmann E, La Harpe R . Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry. 2006; 61(2):240-5. DOI: 10.1016/j.biopsych.2006.04.036. View

15.

Karege F, Perroud N, Burkhardt S, Fernandez R, Ballmann E, La Harpe R . Protein levels of β-catenin and activation state of glycogen synthase kinase-3β in major depression. A study with postmortem prefrontal cortex. J Affect Disord. 2011; 136(1-2):185-188. DOI: 10.1016/j.jad.2011.09.024. View

16.

Li X, Jope R . Is glycogen synthase kinase-3 a central modulator in mood regulation?. Neuropsychopharmacology. 2010; 35(11):2143-54. PMC: 3055312. DOI: 10.1038/npp.2010.105. View

17.

Li X, Friedman A, Zhu W, Wang L, Boswell S, May R . Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder. Biol Psychiatry. 2006; 61(2):216-22. PMC: 1853347. DOI: 10.1016/j.biopsych.2006.02.027. View

18.

Liang M, Chuang D . Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation. J Biol Chem. 2006; 281(41):30479-84. DOI: 10.1074/jbc.M607468200. View

19.

Milanesi E, Zanardini R, Rosso G, Maina G, Barbon A, Mora C . Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues. World J Biol Psychiatry. 2017; 19(8):610-618. DOI: 10.1080/15622975.2017.1282172. View

20.

Munkholm K, Lenskjold T, Jacoby A, Miskowiak K, Vinberg M, Joaquim H . Glycogen Synthase Kinase-3β: Variation over Time and the Possible Association with Mood and Cognition in Healthy Individuals. Neuropsychobiology. 2016; 73(2):108-15. DOI: 10.1159/000444489. View